Literature DB >> 21479093

Potential impact of single-risk-factor versus total risk management for the prevention of cardiovascular events in Seychelles.

Roger Ndindjock1, Jude Gedeon, Shanthi Mendis, Fred Paccaud, Pascal Bovet.   

Abstract

OBJECTIVE: To assess the prevalence of cardiovascular (CV) risk factors in Seychelles, a middle-income African country, and compare the cost-effectiveness of single-risk-factor management (treating individuals with arterial blood pressure ≥ 140/90 mmHg and/or total serum cholesterol ≥ 6.2 mmol/l) with that of management based on total CV risk (treating individuals with a total CV risk ≥ 10% or ≥ 20%).
METHODS: CV risk factor prevalence and a CV risk prediction chart for Africa were used to estimate the 10-year risk of suffering a fatal or non-fatal CV event among individuals aged 40-64 years. These figures were used to compare single-risk-factor management with total risk management in terms of the number of people requiring treatment to avert one CV event and the number of events potentially averted over 10 years. Treatment for patients with high total CV risk (≥ 20%) was assumed to consist of a fixed-dose combination of several drugs (polypill). Cost analyses were limited to medication.
FINDINGS: A total CV risk of ≥ 10% and ≥ 20% was found among 10.8% and 5.1% of individuals, respectively. With single-risk-factor management, 60% of adults would need to be treated and 157 cardiovascular events per 100000 population would be averted per year, as opposed to 5% of adults and 92 events with total CV risk management. Management based on high total CV risk optimizes the balance between the number requiring treatment and the number of CV events averted.
CONCLUSION: Total CV risk management is much more cost-effective than single-risk-factor management. These findings are relevant for all countries, but especially for those economically and demographically similar to Seychelles.

Entities:  

Mesh:

Year:  2011        PMID: 21479093      PMCID: PMC3066521          DOI: 10.2471/BLT.10.082370

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  38 in total

1.  Updated New Zealand cardiovascular disease risk-benefit prediction guide.

Authors:  R Jackson
Journal:  BMJ       Date:  2000-03-11

2.  Two decades of progress in preventing vascular disease.

Authors:  Salim Yusuf
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

3.  Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease.

Authors:  Jonathan Emberson; Peter Whincup; Richard Morris; Mary Walker; Shah Ebrahim
Journal:  Eur Heart J       Date:  2004-03       Impact factor: 29.983

4.  Physician support for a population-based pharmaceutical approach to cardiovascular prevention: not there yet.

Authors:  Christina Huy; David Litaker
Journal:  Prev Med       Date:  2010-12-02       Impact factor: 4.018

5.  Monitoring one-year compliance to antihypertension medication in the Seychelles.

Authors:  Pascal Bovet; Michel Burnier; George Madeleine; Bernard Waeber; Fred Paccaud
Journal:  Bull World Health Organ       Date:  2002       Impact factor: 9.408

6.  Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk.

Authors:  Christopher J L Murray; Jeremy A Lauer; Raymond C W Hutubessy; Louis Niessen; Niels Tomijima; Anthony Rodgers; Carlene M M Lawes; David B Evans
Journal:  Lancet       Date:  2003-03-01       Impact factor: 79.321

7.  2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension.

Authors:  Judith A Whitworth
Journal:  J Hypertens       Date:  2003-11       Impact factor: 4.844

8.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

Authors:  R M Conroy; K Pyörälä; A P Fitzgerald; S Sans; A Menotti; G De Backer; D De Bacquer; P Ducimetière; P Jousilahti; U Keil; I Njølstad; R G Oganov; T Thomsen; H Tunstall-Pedoe; A Tverdal; H Wedel; P Whincup; L Wilhelmsen; I M Graham
Journal:  Eur Heart J       Date:  2003-06       Impact factor: 29.983

9.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321

10.  A strategy to reduce cardiovascular disease by more than 80%.

Authors:  N J Wald; M R Law
Journal:  BMJ       Date:  2003-06-28
View more
  22 in total

1.  Prevalence of Pragmatically Defined High CV Risk and its Correlates in LMIC: A Report From 10 LMIC Areas in Africa, Asia, and South America.

Authors:  Rodrigo M Carrillo-Larco; J Jaime Miranda; Xian Li; Chendi Cui; Xiaolin Xu; Mohammed Ali; Dewan S Alam; Thomas A Gaziano; Rajeev Gupta; Vilma Irazola; Naomi S Levitt; Dorairaj Prabhakaran; Adolfo Rubinstein; Krisela Steyn; Nikhil Tandon; Denis Xavier; Yangfeng Wu; Lijing L Yan
Journal:  Glob Heart       Date:  2016-03

2.  Estimation of the cardiovascular risk using World Health Organization/International Society of Hypertension (WHO/ISH) risk prediction charts in a rural population of South India.

Authors:  Arun Gangadhar Ghorpade; Saurabh RamBihariLal Shrivastava; Sitanshu Sekhar Kar; Sonali Sarkar; Sumanth Mallikarjuna Majgi; Gautam Roy
Journal:  Int J Health Policy Manag       Date:  2015-04-21

3.  Cardiovascular risk in Mozambique: who should be treated for hypertension?

Authors:  Albertino Damasceno; Patrícia Padrão; Carla Silva-Matos; António Prista; Ana Azevedo; Nuno Lunet
Journal:  J Hypertens       Date:  2013-12       Impact factor: 4.844

4.  Cardiovascular event risk estimation among residents of a rural setting in Bayelsa state, Nigeria.

Authors:  Tamaraemumoemi Emmanuella Okoro; Johnbull Jumbo
Journal:  Am J Cardiovasc Dis       Date:  2021-06-15

5.  The global burden of cardiovascular diseases: a challenge to improve.

Authors:  Shanthi Mendis; Oleg Chestnov
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

6.  Challenge for hypertension prevention and control worldwide: the time for action.

Authors:  Daniel Lemogoum
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-07-24       Impact factor: 3.738

Review 7.  Excess Cardiovascular Risk Burden in Jamaican Women Does Not Influence Predicted 10-Year CVD Risk Profiles of Jamaica Adults: An Analysis of the 2007/08 Jamaica Health and Lifestyle Survey.

Authors:  Marshall K Tulloch-Reid; Novie O Younger; Trevor S Ferguson; Damian K Francis; Abdullahi O Abdulkadri; Georgiana M Gordon-Strachan; Shelly R McFarlane; Colette A Cunningham-Myrie; Rainford J Wilks; Simon G Anderson
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

8.  Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study.

Authors:  Linda J Cobiac; Anne Magnus; Jan J Barendregt; Rob Carter; Theo Vos
Journal:  BMC Public Health       Date:  2012-06-01       Impact factor: 3.295

9.  Hypertension and diabetes: entry points for prevention and control of the global cardiovascular epidemic.

Authors:  Shanthi Mendis; Eoin O'Brien; Yackoob Kassim Seedat; Salim Yusuf
Journal:  Int J Hypertens       Date:  2013-04-07       Impact factor: 2.420

10.  Assessment of total cardiovascular risk using WHO/ISH risk prediction charts in three low and middle income countries in Asia.

Authors:  Dugee Otgontuya; Sophal Oum; Brian S Buckley; Ruth Bonita
Journal:  BMC Public Health       Date:  2013-06-05       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.